HUP9603631A2 - Gyógyszerkészítmény - Google Patents

Gyógyszerkészítmény

Info

Publication number
HUP9603631A2
HUP9603631A2 HU9603631A HUP9603631A HUP9603631A2 HU P9603631 A2 HUP9603631 A2 HU P9603631A2 HU 9603631 A HU9603631 A HU 9603631A HU P9603631 A HUP9603631 A HU P9603631A HU P9603631 A2 HUP9603631 A2 HU P9603631A2
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
discordance
metabolite
prevention
subject
Prior art date
Application number
HU9603631A
Other languages
English (en)
Inventor
László Vojcek
Tibor Bedő
Gábor Bartók
Tibor Pók
Zsolt Ágni
Original Assignee
BIOGAL Gyógyszergyár Rt.
László Vojcek
Tibor Bedő
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOGAL Gyógyszergyár Rt., László Vojcek, Tibor Bedő filed Critical BIOGAL Gyógyszergyár Rt.
Priority to HU9603631A priority Critical patent/HU225149B1/hu
Publication of HU9603631D0 publication Critical patent/HU9603631D0/hu
Priority to US09/117,830 priority patent/US5994411A/en
Priority to EP97952124A priority patent/EP0930879B1/en
Priority to PT97952124T priority patent/PT930879E/pt
Priority to CA002244907A priority patent/CA2244907C/en
Priority to DE69715227T priority patent/DE69715227D1/de
Priority to JP10529762A priority patent/JP2000505819A/ja
Priority to ES97952124T priority patent/ES2181051T3/es
Priority to AT97952124T priority patent/ATE223211T1/de
Priority to PCT/HU1997/000090 priority patent/WO1998029103A2/en
Priority to CN97192641A priority patent/CN1116872C/zh
Publication of HUP9603631A2 publication Critical patent/HUP9603631A2/hu
Publication of HUP9603631A3 publication Critical patent/HUP9603631A3/hu
Publication of HU225149B1 publication Critical patent/HU225149B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány tárgya az (I) általánős képletű vegyület, ahől x jelentése1 vagy 2 értékű eszenciális fémiőn, n értéke 1 vagy 2, vagymetabőlitjának alkalmazás magzati retardiáció vagy diszkőrdanciagyógyítására vagy megelőzésére. ŕ
HU9603631A 1996-12-30 1996-12-30 Use of dobesilate salts for the manufacture of medicaments for the treatment or prevention of embryonic retardation or discordance HU225149B1 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
HU9603631A HU225149B1 (en) 1996-12-30 1996-12-30 Use of dobesilate salts for the manufacture of medicaments for the treatment or prevention of embryonic retardation or discordance
CN97192641A CN1116872C (zh) 1996-12-30 1997-12-30 制剂产品
EP97952124A EP0930879B1 (en) 1996-12-30 1997-12-30 Use of calcium dobesilate for the manufacture of a medicament for the treatment of embryonic retardation
US09/117,830 US5994411A (en) 1996-12-30 1997-12-30 Formulated product for embryonic retardation or discordance
PT97952124T PT930879E (pt) 1996-12-30 1997-12-30 Utilizacao de dobesilato de calcio para a preparacao de um medicamento para o tratamento de retardamento embrionario
CA002244907A CA2244907C (en) 1996-12-30 1997-12-30 Formulated product
DE69715227T DE69715227D1 (de) 1996-12-30 1997-12-30 Verwendung von kalzium dobesilat zur herstellung eines arzneimittels zur behandlung von embryonaler zurückgebliebenheit
JP10529762A JP2000505819A (ja) 1996-12-30 1997-12-30 製剤製品
ES97952124T ES2181051T3 (es) 1996-12-30 1997-12-30 Derivados del acido 2,5-dihidroxi-benceno sulfonico para la fabricacion de medicamentos para la prevencion o el tratamiento del atraso embrionario.
AT97952124T ATE223211T1 (de) 1996-12-30 1997-12-30 Verwendung von kalzium dobesilat zur herstellung eines arzneimittels zur behandlung von embryonaler zurückgebliebenheit
PCT/HU1997/000090 WO1998029103A2 (en) 1996-12-30 1997-12-30 Use of calcium dobesilate for the manufacture of a medicament for the treatment of embryonic retardation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9603631A HU225149B1 (en) 1996-12-30 1996-12-30 Use of dobesilate salts for the manufacture of medicaments for the treatment or prevention of embryonic retardation or discordance

Publications (4)

Publication Number Publication Date
HU9603631D0 HU9603631D0 (en) 1997-02-28
HUP9603631A2 true HUP9603631A2 (hu) 1998-09-28
HUP9603631A3 HUP9603631A3 (en) 1999-06-28
HU225149B1 HU225149B1 (en) 2006-07-28

Family

ID=89994597

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9603631A HU225149B1 (en) 1996-12-30 1996-12-30 Use of dobesilate salts for the manufacture of medicaments for the treatment or prevention of embryonic retardation or discordance

Country Status (10)

Country Link
US (1) US5994411A (hu)
EP (1) EP0930879B1 (hu)
JP (1) JP2000505819A (hu)
CN (1) CN1116872C (hu)
AT (1) ATE223211T1 (hu)
DE (1) DE69715227D1 (hu)
ES (1) ES2181051T3 (hu)
HU (1) HU225149B1 (hu)
PT (1) PT930879E (hu)
WO (1) WO1998029103A2 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2180446B1 (es) * 2001-07-02 2004-01-16 Esteve Labor Dr Empleo de derivados de acidos 2,5-dihidroxibencenosulfonicos en la elaboracion de un medicamento para potenciar el efecto de otros farmacos en el tratamiento de la disfuncion erectil.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6163M (hu) * 1966-01-20 1968-07-08

Also Published As

Publication number Publication date
HU225149B1 (en) 2006-07-28
WO1998029103A2 (en) 1998-07-09
ES2181051T3 (es) 2003-02-16
EP0930879B1 (en) 2002-09-04
EP0930879A2 (en) 1999-07-28
HUP9603631A3 (en) 1999-06-28
PT930879E (pt) 2003-01-31
JP2000505819A (ja) 2000-05-16
WO1998029103A3 (en) 1998-08-27
CN1116872C (zh) 2003-08-06
DE69715227D1 (de) 2002-10-10
ATE223211T1 (de) 2002-09-15
US5994411A (en) 1999-11-30
HU9603631D0 (en) 1997-02-28
CN1232390A (zh) 1999-10-20

Similar Documents

Publication Publication Date Title
MX9204661A (es) Compuestos intermedios derivados de eter y procedimiento para su preparacion.
NL1002835A1 (nl) Synergistisch stabilisatormengsel.
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
DE69325130D1 (de) N-sulfonyl-2-oxoindol-derivate mit einer affinität für die vasopressin und/oder ocytocin rezeptoren
TW334418B (en) Stilbene derivatives and pharmaceutical compositions
UA39099C2 (uk) Циклічні азотовмісні похідні, суміш їх ізомерів або окремі ізомери, або їх солі
IE44749L (en) Cyclopeptide
DE69920757D1 (de) Immunsuppressive wirkungen von pteridinderivaten
ATE225772T1 (de) Thrombin-inhibitoren
DK0705100T3 (da) Terapeutiske substituerede guanidiner
ES2181726T3 (es) Amidinoderivados utiles como inhibidores de oxido nitrico sintasa.
IT1285770B1 (it) Composti corticoidei
IE781670L (en) Substituted propenylamines.
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
SE9604348D0 (sv) Användning av hydroxyguanidiner
GB2380939B (en) Treatment or prevention of auto-immune diseases
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
BR9509741A (pt) Composto e uso de composto
GB2331987B (en) Polycyclic sulphamate inhibitors of oestrone sulphatase
DK0671387T3 (da) Ny anvendelse af 1alfa-fluor-25-hydroxy-16-en-23-yn-cholecalciferol
BG104575A (en) Matrix metalloprotease inhibitors
ES8205759A1 (es) Un procedimiento para la preparacion de aminopropenol y pro-pano nitrilos 2 sustituidos.
IT1285096B1 (it) Elemento di minuteria per mobili.
HUP9603631A2 (hu) Gyógyszerkészítmény
FI915245A0 (fi) 7-acyl-3-(substitueradkarbamoyloxi) cefemfoereningar samt foerfarande foer framstaellning av dessa.

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: DR. BEDOE TIBOR, HU

Free format text: FORMER OWNER(S): BIOGAL GYOGYSZERGYAR RT., HU; DR. VOJCEK LASZLO, HU; BIOGAL GYOGYSZERGYAR RT., HU

Owner name: DR. VOJCEK LASZLO, HU

Free format text: FORMER OWNER(S): BIOGAL GYOGYSZERGYAR RT., HU; DR. VOJCEK LASZLO, HU; BIOGAL GYOGYSZERGYAR RT., HU

Owner name: TEVA GYOGYSZERGYAR ZRT., HU

Free format text: FORMER OWNER(S): BIOGAL GYOGYSZERGYAR RT., HU; DR. VOJCEK LASZLO, HU; BIOGAL GYOGYSZERGYAR RT., HU

FH92 Termination of representative

Representative=s name: EMRI-PATENT KFT., HU